• company

    Awakn Life Sciences Corp. (NEO Exchange: AWKN)

    A biotechnology company with clinical operations developing psychedelic medicine to treat addiction. The company has multiple revenue streams across clinics and drug development and a leading research and clinical team. The first 3 UK clinics opened in 2021, targeting 20 clinics by 2024 ~$100M in revenue.

  • company

    Biomind Labs Inc (NEO Exchange: BMND)

    Biomind Labs is Developing the next generation of medicines for the 21st century … the pharmaceutical side of psychedelics.

  • company

    Delic Holdings Corp. (CSE: DELC)

    Delic Holdings is blazing a new trail. While other emerging companies are focused on patent medicine and big pharma for substances that are largely still illegal, Delic identifies fully-legal opportunities to scale under big tent of resources and reach.

  • company

    Red Light Holland (CSE: TRIP)

    Red Light Holland’s goal is to grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can't wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles.